Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 20:24:36 UTC |
---|
Update Date | 2021-09-26 23:15:50 UTC |
---|
HMDB ID | HMDB0258709 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Tandutinib |
---|
Description | Tandutinib, also known as CT 53518 or MLN 518, belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. Based on a literature review a significant number of articles have been published on Tandutinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Tandutinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Tandutinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1 InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38) |
---|
Synonyms | Value | Source |
---|
(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide | ChEBI | CT 53518 | ChEBI | CT-53518 | ChEBI | CT53518 | ChEBI | MLN 518 | ChEBI | MLN-518 | ChEBI | MLN518 | ChEBI | Tandutinibum | ChEBI | 4-(6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide | MeSH |
|
---|
Chemical Formula | C31H42N6O4 |
---|
Average Molecular Weight | 562.703 |
---|
Monoisotopic Molecular Weight | 562.326753862 |
---|
IUPAC Name | 4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide |
---|
Traditional Name | tandutinib |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=C(OCCCN2CCCCC2)C=C2N=CN=C(N3CCN(CC3)C(=O)NC3=CC=C(OC(C)C)C=C3)C2=C1 |
---|
InChI Identifier | InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38) |
---|
InChI Key | UXXQOJXBIDBUAC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | N-arylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - N-arylpiperazine
- Quinazolinamine
- N-phenylurea
- Diazanaphthalene
- Quinazoline
- Piperazine-1-carboxamide
- Phenoxy compound
- Anisole
- Dialkylarylamine
- Phenol ether
- Alkyl aryl ether
- Aminopyrimidine
- Monocyclic benzene moiety
- Imidolactam
- Benzenoid
- Piperidine
- Pyrimidine
- Heteroaromatic compound
- Carbonic acid derivative
- Tertiary amine
- Tertiary aliphatic amine
- Urea
- Azacycle
- Ether
- Amine
- Organic nitrogen compound
- Organic oxygen compound
- Carbonyl group
- Organic oxide
- Hydrocarbon derivative
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Tandutinib,1TMS,isomer #1 | COC1=CC2=C(N3CCN(C(=O)N(C4=CC=C(OC(C)C)C=C4)[Si](C)(C)C)CC3)N=CN=C2C=C1OCCCN1CCCCC1 | 4597.0 | Semi standard non polar | 33892256 | Tandutinib,1TMS,isomer #1 | COC1=CC2=C(N3CCN(C(=O)N(C4=CC=C(OC(C)C)C=C4)[Si](C)(C)C)CC3)N=CN=C2C=C1OCCCN1CCCCC1 | 3977.6 | Standard non polar | 33892256 | Tandutinib,1TMS,isomer #1 | COC1=CC2=C(N3CCN(C(=O)N(C4=CC=C(OC(C)C)C=C4)[Si](C)(C)C)CC3)N=CN=C2C=C1OCCCN1CCCCC1 | 6333.4 | Standard polar | 33892256 | Tandutinib,1TBDMS,isomer #1 | COC1=CC2=C(N3CCN(C(=O)N(C4=CC=C(OC(C)C)C=C4)[Si](C)(C)C(C)(C)C)CC3)N=CN=C2C=C1OCCCN1CCCCC1 | 4766.1 | Semi standard non polar | 33892256 | Tandutinib,1TBDMS,isomer #1 | COC1=CC2=C(N3CCN(C(=O)N(C4=CC=C(OC(C)C)C=C4)[Si](C)(C)C(C)(C)C)CC3)N=CN=C2C=C1OCCCN1CCCCC1 | 4097.0 | Standard non polar | 33892256 | Tandutinib,1TBDMS,isomer #1 | COC1=CC2=C(N3CCN(C(=O)N(C4=CC=C(OC(C)C)C=C4)[Si](C)(C)C(C)(C)C)CC3)N=CN=C2C=C1OCCCN1CCCCC1 | 6308.3 | Standard polar | 33892256 |
|
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tandutinib 10V, Positive-QTOF | splash10-03di-0202390000-6dfff2db57312f0c8fa7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tandutinib 20V, Positive-QTOF | splash10-002k-9516330000-85cc72788befe845acff | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tandutinib 40V, Positive-QTOF | splash10-0fc3-9866000000-e5bf245e71e62492195c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tandutinib 10V, Negative-QTOF | splash10-03di-1313490000-e9a917b16090c86ae226 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tandutinib 20V, Negative-QTOF | splash10-01qi-6835950000-b6ca0e64280a8b5d263d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tandutinib 40V, Negative-QTOF | splash10-0pc3-5369100000-d2cead28342ddbaae843 | 2016-08-03 | Wishart Lab | View Spectrum |
|
---|